These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9825707)

  • 1. Treating Parkinson's disease.
    Standaert D
    Health News; 1998 Nov; 4(14):1-2. PubMed ID: 9825707
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological therapy of complicated Parkinson's disease].
    Jiménez-Jiménez FJ; Molina JA
    Rev Neurol; 1997 Aug; 25 Suppl 2():S170-9. PubMed ID: 9280685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatments for Parkinson's disease.
    Health News; 2000 Jun; 6(6):8. PubMed ID: 10865523
    [No Abstract]   [Full Text] [Related]  

  • 4. Levodopa in the treatment of Parkinson's disease: current controversies.
    Gerlach M; Reichmann H; Riederer P
    Mov Disord; 2005 May; 20(5):643; author reply 643-4. PubMed ID: 15732130
    [No Abstract]   [Full Text] [Related]  

  • 5. Ropinirole as compared with levodopa in Parkinson's disease.
    Hiner BC; Earnhart M
    N Engl J Med; 2000 Sep; 343(12):884; author reply 885. PubMed ID: 11001684
    [No Abstract]   [Full Text] [Related]  

  • 6. Current controversies: levodopa in the treatment of Parkinson's disease.
    Sharma JC; Vassallo M; Ross IN
    Mov Disord; 2005 May; 20(5):642-3; author reply 643-4. PubMed ID: 15732129
    [No Abstract]   [Full Text] [Related]  

  • 7. [Arguments in favor of the early treatment of Parkinson's disease with L-Dopa].
    Broussolle E
    Rev Neurol (Paris); 1999 Jan; 155(1):27-33. PubMed ID: 10093845
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pergolide: a useful agonist for the treatment of Parkinson disease].
    Bonnet AM; Houeto JL
    Rev Neurol (Paris); 2002 Jul; 158(6-7):744-5. PubMed ID: 12486908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep brain stimulation in Parkinson's disease: opposite effects of stimulation in the pallidum.
    Bejjani BP; Damier P; Arnulf I; Papadopoulos S; Bonnet AM; Vidailhet M; Agid Y; Pidoux B; Cornu P; Dormont D; Marsault C
    Mov Disord; 1998 Nov; 13(6):969-70. PubMed ID: 9827624
    [No Abstract]   [Full Text] [Related]  

  • 10. New hope for Parkinson's disease.
    Johns Hopkins Med Lett Health After 50; 1998 Oct; 10(8):6-7. PubMed ID: 9766182
    [No Abstract]   [Full Text] [Related]  

  • 11. Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?
    Bejjani BP; Arnulf I; Demeret S; Damier P; Bonnet AM; Houeto JL; Agid Y
    Ann Neurol; 2000 May; 47(5):655-8. PubMed ID: 10805339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levodopa in the early treatment of Parkinson's disease.
    Murata M
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S17-20. PubMed ID: 19131036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient acute depression induced by high-frequency deep-brain stimulation.
    Bejjani BP; Damier P; Arnulf I; Thivard L; Bonnet AM; Dormont D; Cornu P; Pidoux B; Samson Y; Agid Y
    N Engl J Med; 1999 May; 340(19):1476-80. PubMed ID: 10320386
    [No Abstract]   [Full Text] [Related]  

  • 14. Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.
    Kondo T
    J Neurol; 2002 Sep; 249 Suppl 2():II25-9. PubMed ID: 12375060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease.
    DeLong M
    Neurobiol Dis; 2000 Oct; 7(5):559-60. PubMed ID: 11042077
    [No Abstract]   [Full Text] [Related]  

  • 16. Levodopa-dyskinesia incidence by age of Parkinson's disease onset.
    Kumar N; Van Gerpen JA; Bower JH; Ahlskog JE
    Mov Disord; 2005 Mar; 20(3):342-4. PubMed ID: 15580606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease, subthalamic stimulation, and selection of candidates: a pathological study.
    Jarraya B; Bonnet AM; Duyckaerts C; Houeto JL; Cornu P; Hauw JJ; Agid Y
    Mov Disord; 2003 Dec; 18(12):1517-20. PubMed ID: 14673889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease. New treatments slow onslaught of symptoms.
    Henkel J
    FDA Consum; 1998; 32(4):13-8. PubMed ID: 9684562
    [No Abstract]   [Full Text] [Related]  

  • 19. Limitations of current Parkinson's disease therapy.
    Rascol O; Payoux P; Ory F; Ferreira JJ; Brefel-Courbon C; Montastruc JL
    Ann Neurol; 2003; 53 Suppl 3():S3-12; discussion S12-5. PubMed ID: 12666094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease.
    Fox S; Silverdale M; Kellett M; Davies R; Steiger M; Fletcher N; Crossman A; Brotchie J
    Mov Disord; 2004 May; 19(5):554-60. PubMed ID: 15133820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.